TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

R Fagerholm; S Khan; MK (Marjanka) Schmidt; M Garcia-Closas; P Heikkila; J Saarela; J Beesley; M Jamshidi; K Aittomaki; JJ Liu; HR Ali; IL Andrulis; MW Beckmann; S Behrens; FM Blows; H Brenner; J Chang-Claude; FJ Couch; K Czene; PA Fasching; J Figueroa; G Floris; G Glendon; Q Guo; P Hall; E Hallberg; U Hamann; B Holleczek; Maartje Hooning; JL Hopper; Agnes Jager; M Kabisch; R Keeman; VM Kosma; D Lambrechts; A Lindblom; A Mannermaa; S Margolin; E Provenzano; M Shah; MC Southey; J Dennis; M Lush; K Michailidou; Q Wang; MK Bolla; AM Dunning; DF Easton; PDP Pharoah; G Chenevix-Trench; C Blomqvist; H Nevanlinna

doi:10.18632/oncotarget.15110

TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

R Fagerholm, S Khan, MK (Marjanka) Schmidt, M Garcia-Closas, P Heikkila, J Saarela, J Beesley, M Jamshidi, K Aittomaki, JJ Liu, HR Ali, IL Andrulis, MW Beckmann, S Behrens, FM Blows, H Brenner, J Chang-Claude, FJ Couch, K Czene, PA FaschingJ Figueroa, G Floris, G Glendon, Q Guo, P Hall, E Hallberg, U Hamann, B Holleczek, Maartje Hooning, JL Hopper, Agnes Jager, M Kabisch, R Keeman, VM Kosma, D Lambrechts, A Lindblom, A Mannermaa, S Margolin, E Provenzano, M Shah, MC Southey, J Dennis, M Lush, K Michailidou, Q Wang, MK Bolla, AM Dunning, DF Easton, PDP Pharoah, G Chenevix-Trench, C Blomqvist, H Nevanlinna

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

8 Citations (Scopus)

3 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	18381-18398
Number of pages	18
Journal	Oncotarget
Volume	8
Issue number	11
DOIs	https://doi.org/10.18632/oncotarget.15110
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.18632/oncotarget.15110

REPUB_98631_OA.pdfFinal published version, 1.81 MB

http://hdl.handle.net/1765/98631

Cite this

Fagerholm, R., Khan, S., Schmidt, MK., Garcia-Closas, M., Heikkila, P., Saarela, J., Beesley, J., Jamshidi, M., Aittomaki, K., Liu, JJ., Ali, HR., Andrulis, IL., Beckmann, MW., Behrens, S., Blows, FM., Brenner, H., Chang-Claude, J., Couch, FJ., Czene, K., ... Nevanlinna, H. (2017). TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer. Oncotarget, 8(11), 18381-18398. https://doi.org/10.18632/oncotarget.15110

@article{286f957fd55641a09f8d393b8cc28bde,

title = "TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer",

author = "R Fagerholm and S Khan and Schmidt, {MK (Marjanka)} and M Garcia-Closas and P Heikkila and J Saarela and J Beesley and M Jamshidi and K Aittomaki and JJ Liu and HR Ali and IL Andrulis and MW Beckmann and S Behrens and FM Blows and H Brenner and J Chang-Claude and FJ Couch and K Czene and PA Fasching and J Figueroa and G Floris and G Glendon and Q Guo and P Hall and E Hallberg and U Hamann and B Holleczek and Maartje Hooning and JL Hopper and Agnes Jager and M Kabisch and R Keeman and VM Kosma and D Lambrechts and A Lindblom and A Mannermaa and S Margolin and E Provenzano and M Shah and MC Southey and J Dennis and M Lush and K Michailidou and Q Wang and MK Bolla and AM Dunning and DF Easton and PDP Pharoah and G Chenevix-Trench and C Blomqvist and H Nevanlinna",

year = "2017",

doi = "10.18632/oncotarget.15110",

language = "Undefined/Unknown",

volume = "8",

pages = "18381--18398",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "11",

}

Fagerholm, R, Khan, S, Schmidt, MK, Garcia-Closas, M, Heikkila, P, Saarela, J, Beesley, J, Jamshidi, M, Aittomaki, K, Liu, JJ, Ali, HR, Andrulis, IL, Beckmann, MW, Behrens, S, Blows, FM, Brenner, H, Chang-Claude, J, Couch, FJ, Czene, K, Fasching, PA, Figueroa, J, Floris, G, Glendon, G, Guo, Q, Hall, P, Hallberg, E, Hamann, U, Holleczek, B, Hooning, M, Hopper, JL, Jager, A, Kabisch, M, Keeman, R, Kosma, VM, Lambrechts, D, Lindblom, A, Mannermaa, A, Margolin, S, Provenzano, E, Shah, M, Southey, MC, Dennis, J, Lush, M, Michailidou, K, Wang, Q, Bolla, MK, Dunning, AM, Easton, DF, Pharoah, PDP, Chenevix-Trench, G, Blomqvist, C & Nevanlinna, H 2017, 'TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer', Oncotarget, vol. 8, no. 11, pp. 18381-18398. https://doi.org/10.18632/oncotarget.15110

TY - JOUR

T1 - TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

AU - Fagerholm, R

AU - Khan, S

AU - Schmidt, MK (Marjanka)

AU - Garcia-Closas, M

AU - Heikkila, P

AU - Saarela, J

AU - Beesley, J

AU - Jamshidi, M

AU - Aittomaki, K

AU - Liu, JJ

AU - Ali, HR

AU - Andrulis, IL

AU - Beckmann, MW

AU - Behrens, S

AU - Blows, FM

AU - Brenner, H

AU - Chang-Claude, J

AU - Couch, FJ

AU - Czene, K

AU - Fasching, PA

AU - Figueroa, J

AU - Floris, G

AU - Glendon, G

AU - Guo, Q

AU - Hall, P

AU - Hallberg, E

AU - Hamann, U

AU - Holleczek, B

AU - Hooning, Maartje

AU - Hopper, JL

AU - Jager, Agnes

AU - Kabisch, M

AU - Keeman, R

AU - Kosma, VM

AU - Lambrechts, D

AU - Lindblom, A

AU - Mannermaa, A

AU - Margolin, S

AU - Provenzano, E

AU - Shah, M

AU - Southey, MC

AU - Dennis, J

AU - Lush, M

AU - Michailidou, K

AU - Wang, Q

AU - Bolla, MK

AU - Dunning, AM

AU - Easton, DF

AU - Pharoah, PDP

AU - Chenevix-Trench, G

AU - Blomqvist, C

AU - Nevanlinna, H

PY - 2017

Y1 - 2017

U2 - 10.18632/oncotarget.15110

DO - 10.18632/oncotarget.15110

M3 - Article

VL - 8

SP - 18381

EP - 18398

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 11

ER -